Biocept receives Investment Bank Analyst Rating Update
- ByInvesting.com-
Symbol | Exchange | Currency |
|---|
Investing.com - Biocept reported on Monday third quarter earnings that beat analysts' forecasts and revenue that topped expectations. Biocept announced earnings per share of...
Investing.com - Biocept reported on Friday third quarter earnings that missed analysts' forecasts and revenue that topped expectations. Biocept announced earnings per share of...
Well, let’s just take a moment today and say one final goodbye to September. Here’s your hat, and there’s the door. The past month saw stocks on a downward tear...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
Biocept, Inc. is a molecular oncology diagnostics company. The Company focuses on developing and commercializing clinical diagnostic laboratory assays designed to identify tumor cells and cell-free tumor deoxyribonucleic acid (DNA) from blood, and cerebrospinal fluid (CSF). Its product is branded and trademarked under the name of CNSide. In addition to CNSide, its current blood-based testing includes its Target Selector technologies, which enables detection of specific gene mutations, such as EGFR, KRAS or BRAF, in cell-free ctDNA from blood samples, as well as specific protein and gene alterations, such as HER2 amplification, in circulating tumor cells (CTCs) isolated from blood. Its multi-modality combination of a cell capture and analysis method used with a cell-free tumor DNA approach provides both high-sensitivity and specificity and is applicable to a range of diagnostic applications in patients with metastatic carcinoma. It provides blood-based liquid biopsy technology.
| Average | 4.000 (+619.424% Upside) |
| High | 4.000 |
| Low | 4.000 |
| Price | 0.556 |
| No. of Analysts | 1 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Strong Sell | Sell | Strong Sell |
| Technical Indicators | Sell | Buy | Buy | Sell | Strong Sell |
| Summary | Sell | Neutral | Neutral | Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 8.36 | 8.53 | 8.31 | -0.040 | -0.48% | 3.71M | Sydney | |||
| 13.54 | 13.58 | 13.31 | +0.20 | +1.50% | 99.34K | Sydney | |||
| 22.275 | 22.65 | 22.07 | -0.035 | -0.16% | 1.14M | Sydney | |||
| 7.59 | 7.64 | 7.56 | -0.06 | -0.78% | 603.07K | Sydney | |||
| 186.71 | 188.23 | 185.75 | -0.630 | -0.34% | 207.40K | Sydney | |||
| 110.02 | 110.81 | 109.89 | -0.040 | -0.04% | 574.74K | Sydney | |||
| 4.13 | 4.14 | 4.09 | +0.050 | +1.23% | 7.76M | Sydney | |||
| 25.39 | 25.48 | 25.06 | +0.300 | +1.20% | 2.91M | Sydney | |||
| 3.15 | 3.15 | 3.15 | +0.05 | +1.61% | 990.00 | Sydney | |||
| 1.705 | 1.785 | 1.695 | -0.035 | -2.01% | 421.50K | Sydney | |||
| 0.66 | 0.68 | 0.65 | 0.00 | +0.38% | 3.34M | Sydney | |||
| 0.268 | 0.275 | 0.265 | +0.008 | +2.88% | 25.35M | Sydney | |||
| 49.81 | 50.045 | 49.54 | +0.430 | +0.87% | 3.15M | Sydney | |||
| 0.845 | 0.865 | 0.84 | 0.00 | 0.00% | 375.89K | Sydney | |||
| 9.91 | 10.10 | 9.82 | +0.03 | +0.25% | 435.01K | Sydney |